Drug · DIN 02496348
NUBEQA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 24, 2020; first marketed March 24, 2020.
- Drug Identification Number (DIN)
- 02496348
- Company (DIN owner)
- Bayer Inc.Elkhart, Indiana, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Darolutamide L02BB06
- Class
- Human
- Record last updated
- September 15, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DAROLUTAMIDE | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 20, 2020: NOC 23233New Drug Submission (NDS)